NIM
CGEM icon

NEOS Investment Management’s Cullinan Oncology CGEM Stock Holding History

NEOS Investment Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,519
Closed -$388K – 593
2025
Q4 		$388K Buy
+37,519
New +$338K ﹤0.01% 626
2025
Q3 		– Sell
-42,692
Closed -$321K – 634
2025
Q2 		$321K Buy
42,692
+3,528
+9% +$28.3K ﹤0.01% 579
2025
Q1 		$296K Buy
39,164
+10,731
+38% +$103K 0.01% 556
2024
Q4 		$346K Buy
28,433
+2,793
+11% +$40.1K 0.01% 546
2024
Q3 		$429K Buy
25,640
+1,617
+7% +$28.7K 0.01% 510
2024
Q2 		$419K Buy
24,023
+7,635
+47% +$163K 0.02% 482
2024
Q1 		$279K Buy
16,388
+482
+3% +$7.45K 0.02% 502
2023
Q4 		$162K Buy
+15,906
New +$141K 0.02% 506

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

NEOS Investment Management's CGEM Position: Q1 2026 in Review

NEOS Investment Management sold out of Cullinan Oncology (CGEM) in Q1 2026, closing a stake of 37,519 shares — an estimated $388K sold.

NEOS Investment Management first reported a position in CGEM in Q4 2023 and held it in 8 quarters. The position peaked at $429K in Q3 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • NEOS Investment Management reported no remaining Cullinan Oncology position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 37,519 Cullinan Oncology shares in Q1 2026, an estimated $388K.
  • NEOS Investment Management first reported a position in Cullinan Oncology in Q4 2023 and held it in 8 quarters.
  • NEOS Investment Management's Cullinan Oncology position peaked at $429K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.